Oral Session 3-12C Bone marrow failure: Epidemiology and pathology

[OS3-12C-6] Response to IST in PNH(+) BMF patients with a history of chemo- or radiotherapy

Noriharu Nakagawa^1,2, Mikoto Tanabe², Ishikazu Mizuno³, Satoshi Morishige⁴, Shuji Matsuzawa⁵, Takahiko Ito⁶, Masahiko Sumi⁷, Nobuyuki Takayama⁸, Ken Ishiyama², Hirohito Yamazaki⁹, Shinji Nakao² (1.Dept. Hematology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan, 2.Dept. Hematology, Kanazawa University Hospital, Kanazawa, Japan, 3.Dept. Hematology, Hyogo Cancer Center, Akashi, Japan, 4.Div. Hematology and Oncology, Kurume University School, Kurume, Japan, 5.Dept. Hematology, NHO Matsumoto Medical Center Matsumoto Hospital, Matsumoto, Japan, 6.Dept. Hematology, JCHO Kani Tono Hospital, Kani, Japan, 7.Dept. Hematology, Nagano Red Cross Hospital, Nagano, Japan, 8.Second Department of Internal Medicine, Kyorin University School, Mitaka, Japan, 9.Div. Transfusion Medicine, Kanazawa University Hospital, Kanazawa, Japan)